Metabo

• Project Presentation
  • Project Data
  • Project Overview
  • METABO Scenarios
  • Main Challenges
  • Consortium Partners
  • Target Market
  • Current Project Status
• Scientific Background
  • Diabetes Trends
  • Types of Diabetes
  • Diabetes Complications
  • Validation Sites
• Project Parameters
  • Main objectives
  • Milestones & Measures
  • Project Deliverables
• Approach and Innovation
  • Technological Approach
  • Integrated Platform
  • Benefits & Results
• Events & Media
  • News & Events
  • Media & Press
• Relevant Links
  • European Commission
  • Related Projects
  • Related Links
  • Platform Models (view)
  • Platform for modeling
• Contact Information
• Glossary
• Guest Book
• Photo Galeery
• Intranet Section
• Metabo Intranet

Metabo Project

METABO scenarios

In order to improve the pragmatic approach of the project and address diabetes control through the real every-day diabetic-life situations, we identified six different “segments”, corresponding to six different scenarios of use for the METABO platform. These use cases are, in fact, six possible applications of the METABO to manage specific problems related to diabetes control. The identification of the segments aims at improving understanding and applicability of the METABO approach by patients, doctors and policy makers and expanding the role of METABO in disease management over and beyond a simple IT tool for glucose control.

The following segmentation has been chosen for a subsequent study of the patients needs:

1. Changes in the environment: This segment is dedicated to the study of the conditions in which the users are exposed to changes in their usual environment, no matter what these changes are, so that they cause a disruption in their treatment routine.
2. Physical exercise. This segment intends to focus on the effect of physical activity over glucose metabolism and diabetes control.
3. Sudden hypoglycemia prediction: One of the most important problems related to hypoglycemia is the fact that diabetics tend to loose awareness of the early, autonomic symptoms (showing a glucose fall) as their disease advances. This can lead to extraordinary situations and, sometimes, to the death of the patient. For this reason, the indirect study of hypoglycemia signs has become a main subject and this segment will focus on its investigation. It is of special relevance the fact that this study is very innovative and has not been performed before.
4. Lack of motivation: In Diabetes Mellitus, especially in T1DM but also in T2DM, there is the need to deal with a very important psychosomatic complex, whose comprehension is vital to provide an adequate care to the patient. There are a great amount of factors that may cause the non-adherence of the patient to the treatment, leading to an instable metabolic state that will have long term health consequences.
5. Unstable diabetes control: Segment V of METABO will address the case of non-brittle patients who cannot reach metabolic stability despite the best available treatment strategy has been put in place. METABO will, thus, focus in isolating the different factors that are likely to be studied, such as food intake, physical activity, insulin intake, glucose in blood, etc.
6. Comorbidity disease management: In this segment, the METABO project will address the case of a diabetic patient who is also affected by a second disease which might or might not be directly related to diabetes. Patients with co-morbidities (i.e. the co-presence of multiple major diseases) represent a significant challenge for clinical medicine as one disease may affect progression and response to treatment of the other.

This classification will define the future target market since the different needs and issues that the project addresses here are shared by most of the diabetic patients and, in some cases, a single case can be identified in more than one of these segments.